Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 77% below Graham Number ($10.29) — significant margin of safety
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -264.4%
- Revenue growing at 24% annually
Vyome Holdings, Inc. - Common Stock (HIND) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $16 million . Key value metrics: P/E ratio 0.2, P/B ratio 7.52, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Vyome Holdings, Inc. - Common Stock — Fundamental Analysis Summary
Vyome Holdings, Inc. - Common Stock (HIND) is trading 77% below its Graham Number of $10.29 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 0.2x.
On financial health, HIND shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -264.4% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 2.86.
StockPik's composite Value Score for HIND is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HIND reports a high gross margin of 87.3% (sector average: 39.4%) and a negative operating margin of -973.7%.
HIND shows revenue growing at 24% year-over-year, with earnings declining at 44%.